A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis

Altoona Center for Clinical Research, Duncansville

East Pennsylvania Rheumatology Association, Bethlehem

Arthritis Center and Carolina Bone and Joint, Charlotte

Arthritis and Rheumatic Disease Specialties, Aventura

Sarasota Arthritis Research Center, Sarasota

Paddock Park Clinical Research, Ocala

Arthritis Research of Florida, Inc., Palm Harbor

Montgomery Rheumatology Associates, Montgomery

Illinois Bone & Joint Institute, Morton Grove

Wichita Clinic, Wichita

Arthritis Center of Nebraska, Lincoln

Rheumatology and Internal Medicine, Amarillo

National Jewish Medical and Research Center, Denver

Denver Arthritis Clinic, Denver

University of Utah Division of Rheumatology, Salt Lake City

East Valley Rheumatology & Osteoporosis, Gilbert

Radiant Research, Scottsdale

Arthritis Center of Reno, Reno

Arthritis Medical Center of the Central Coast, Santa Maria

New England Research Associates, Trumbull